Hashimoto’s thyroiditis worsens ovaries in polycystic ovary syndrome patients compared to Anti-Müllerian hormone levels
Open Access
- 9 March 2021
- journal article
- research article
- Published by Springer Nature in BMC Endocrine Disorders
- Vol. 21 (1) , 1-8
Abstract
Background: The human ovary is the target of autoimmune attack in cases of autoimmune disorders, which can cause ovarian dysfunction. Due to the higher prevalence of Hashimoto’s Thyroiditis (HT) in Polycystic Ovary Syndrome (PCOS) patients, we aimed to evaluate ovarian reserve and the effect of autoimmune exposure time on ovarian reserve in PCOS patients with HT by Anti-Müllerian hormone (AMH) levels. Methods: Forty-six PCOS patients and 46 PCOS with HT diagnosed patients who are between 18 and 35 years old were recruited for this study. Detailed medical histories were obtained from all participants. Polycystic ovary image was evaluated and antral follicles were counted by transvaginal ultrasound. Modified Ferriman Gallwey score, body mass index, waist/hip ratio of the patients were examined. Hormonal, biochemical profiles and AMH levels of the patients were evaluated during the early follicular phase. The data of both groups were statistically analyzed with SPSS 18.0. Results: 20 (43.5%) patients in the PCOS group were fertile, 8 (17.4%) patients in the PCOS + HT group were fertile, fertility rate was significantly lower in PCOS + HT group. The mean AMH value was 8.8 ± 8.8 in the PCOS + HT group and 12.4 ± 8.1 in the PCOS group and it was significantly lower in the PCOS + HT group (p = 0.043). AMH values were significantly negatively correlated with anti-thyroid peroxidase antibody (anti-TPO) level and the duration of HT. There was a significant positive correlation between the anti-TPO level and the duration of HT. Conclusıon: We pointed out that the coexistence of PCOS and HT, two prevalent diseases of reproductive age, further diminished ovarian reserve. More exposure of the ovaries to autoantibodies can cause ovarian destruction, similar to the thyroid gland like HT. Because of all these close relations with PCOS and thyroid dysfunctions, we recommend evaluating both thyroid autoantibodies and hormone levels in PCOS patients at the first visit. Patients with PCOS + HT should be monitored more closely to determine the fertility treatment options and control premature ovarian failure (POF) table.Keywords
This publication has 41 references indexed in Scilit:
- Age-specific serum anti-Müllerian hormone values for 17,120 women presenting to fertility centers within the United StatesFertility and Sterility, 2011
- Female Infertility Related to Thyroid Autoimmunity: The Ovarian Follicle HypothesisAmerican Journal of Reproductive Immunology, 2011
- Elevated antithyroid peroxidase antibodies indicating Hashimoto's thyroiditis are associated with the treatment response in infertile women with polycystic ovary syndromeFertility and Sterility, 2010
- Thyroid function and pregnancy: Before, during and beyondJournal of Obstetrics and Gynaecology, 2010
- Serologic markers of autoimmunity in women with polycystic ovary syndromeFertility and Sterility, 2010
- The role of thyroid autoimmunity in fertility and pregnancyNature Clinical Practice Endocrinology & Metabolism, 2008
- Functional autoantibodies, a new paradigm in autoimmunity?Autoimmunity Reviews, 2007
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndromeFertility and Sterility, 2004
- Thyroid Dysfunction and Autoimmunity in Infertile WomenThyroid®, 2002
- Premature ovarian failure: autoimmunity and natural historyClinical Endocrinology, 1993